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Abstract
Background: Little is known about the mechanism underlying the genotoxicity observed in the liver following
pulmonary exposure to carbon black (CB) nanoparticles (NPs). The genotoxicity could be caused by the presence of
translocated particles or by circulating inflammatory mediators released during pulmonary inflammation and
acute-phase response. To address this, we evaluated induction of pulmonary inflammation, pulmonary and
hepatic acute-phase response and genotoxicity following exposure to titanium dioxide (TiO2), cerium oxide
(CeO2) or CB NPs. Female C57BL/6 mice were exposed by intratracheal instillation, intravenous injection or
oral gavage to a single dose of 162 μg NPs/mouse and terminated 1, 28 or 180 days post-exposure alongside
vehicle control.
Results: Liver DNA damage assessed by the Comet Assay was observed after intravenous injection and
intratracheal instillation of CB NPs but not after exposure to TiO2 or CeO2. Intratracheal exposure to NPs
resulted in pulmonary inflammation in terms of increased neutrophils influx for all NPs 1 and 28 days post-exposure.
Persistent pulmonary acute phase response was detected for all NPs at all three time points while only a transient
induction of hepatic acute phase response was observed. All 3 materials were detected in the liver by enhanced
darkfield microscopy up to 180 days post-exposure. In contrast to TiO2 and CeO2 NPs, CB NPs generated ROS in an
acellular assay.
Conclusions: Our results suggest that the observed hepatic DNA damage following intravenous and intratracheal
dosing with CB NPs was caused by the presence of translocated, ROS-generating, particles detected in the liver
rather than by the secondary effects of pulmonary inflammation or hepatic acute phase response.
Keywords: Carbon black, Cerium oxide, Titanium dioxide, Nanoparticles, Liver, Intratracheal instillation, Intravenous
injection, Oral gavage, Genotoxicity, DNA strand breaks
Background
The wide range of nanoparticles (NPs) applications leads
to increased risk of unintended human exposure for
consumers as well as for workers in the occupational en-
vironment. Inhaled NPs constitute a potential health risk
[1] and therefore, understanding the fate and toxicity
following pulmonary exposure to NPs has become an
important issue.
Inhalation of particles leads to size dependent pulmonary
deposition [2, 3]. A large fraction of the pulmonary depos-
ited particles is removed from the upper airways by the
mucociliary escalator and subsequently swallowed resulting
in secondary exposure through the oral route [4–7]. In
addition, a small fraction of the pulmonary deposited parti-
cles undergo translocation and primarily accumulate in the
liver but also in other secondary organs [7–12].
Inhalation and intratracheal instillation of NPs induce
pulmonary inflammation which is accompanied by a
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pulmonary acute phase response [13–15]. We have pre-
viously shown that instillation and inhalation of CB
Printex 90 NPs induced hepatic genotoxicity in terms of
increased DNA strand break levels and increased levels
of oxidative DNA damage [14, 16–18]. However, the
underlying mechanism is not clear. Exposure to particles
can cause primary or secondary genotoxicity. Primary
genotoxicity refers to DNA damage caused by direct
physical interaction between particles and the genomic
DNA and by ROS-mediated DNA damage in the ab-
sence of inflammation. Secondary genotoxicity refers to
DNA damage as a result of action of reactive oxygen
species (ROS) and reactive nitrogen species (RNS) as
well as other secondary mediators (cytokines, chemo-
kines) that are generated during particle-induced inflam-
mation and acute phase response in the lungs that could
initiate DNA damaging processes in the liver including
induction of a hepatic acute phase response [19, 20].
The NPs used in this work, i.e. titanium dioxide
(TiO2), cerium oxide (CeO2) and carbon black (CB) are
all worldwide-used high-volume nanomaterials. More-
over, CB is a well-known ROS generator [21] and has
been shown to be mutagenic [22]. TiO2-induced oxida-
tive stress [23] and genotoxicity [24, 25] were also previ-
ously reported. In addition, CeO2-mediated DNA
damages were confirmed in both in vivo [26] and in
vitro [27] studies. CB NPs were included in the study as
the DNA damaging test material in liver whereas TiO2
and CeO2 NPs were included as inflammogenic NPs
with relatively low ROS generating abilities.
The objective of the present study was to assess the
etiology of particle-induced genotoxicity in the liver. We
therefore dosed mice with 3 different nanomaterials:
TiO2, CeO2 and CB by pulmonary, oral and intravenous
dosing to determine whether the observed hepatic DNA
strand breaks are caused by secondary genotoxicity from
pulmonary or hepatic inflammatory and acute phase re-
sponses or by direct genotoxicity from translocated NPs.
Oral exposure was included to assess the contribution
from the secondary oral exposure that accompanies par-
ticle clearance by the mucociliary escalator. Intravenous
(IV) exposure was included to assess the effect of par-
ticle translocation and hepatic accumulation.
Methods
Animal study
Three hundred twenty four young adult C57BL/6
(B6JBOM-F) female mice were purchased from Taconic
(Ry, Denmark) at 6 weeks of age and body weight of
17.5 ± 0.9 g (mean ± SD) and allowed to acclimate for
2 weeks before exposure. All animals were provided with
the standard pellet diet (Altromin No. 1324) and acid-
ified water ad libitum and housed in polypropylene cages
with bedding and enrichment at controlled temperature
22 ± 1 °C and humidity of 55% ± 5 and with the reverse
12 h light/12 h dark cycle. The study was conducted in
the agreement with the Danish Animal Experimental In-
spectorate under the Ministry of Justice (Permission
2012–15–2934-00089 C6) and the Technical University
of Denmark’s animal welfare protocol.
Preparation of exposure stock
TiO2 was provided by NanoAmor, CeO2 was provided by
Degussa-Quimidroga and CB (Printex 90) was provided
by Evonik Degussa. Physicochemical characteristics of par-
ticles are presented in Table 1. All three materials were
suspended in 2% v/v mouse serum from C57BL/6 mice in
nanopure water to a final concentration of 3.24 mg/ml
and dispersed by sonication for 15 min using Microson
ultrasonic cell disruptor (XL-2000, Microson™, Qsonica,
LLC.) equipped with disruptor horn with a diameter of
3.2 mm and maximum peak-to-peak amplitude of
180 μm. Suspensions were cooled on ice during the sonic-
ation procedure to prevent sample overheating. Control
vehicle, 2% serum in nanopure water, was also sonicated
prior to exposure as described above.
Dynamic light scattering (Malvern Zetasizer Nano ZS,
Malvern Instruments, UK) was used to determine the
hydrodynamic size distribution in the sonicated suspen-
sions before administration. The suspensions were pre-
pared as described above and measured in transparent
1 ml disposable cuvettes at the temperature of 25 °C. Six
consecutively repeated measurements were performed.
Duration of each measurement as well as attenuator
index and measurement position within the cuvette were
determined automatically by the instrument. For the cal-
culation of the number-based particle size distribution,
refractive index and extinction coefficient (absorption)
for the tested materials were as followed: 2.9 and 0.1, re-
spectively, for TiO2, 2.2 and 0.1, respectively, for CeO2,
2.02 and 2.0, respectively, for CB NPs.
Exposure of mice
The mice (n = 9 per group) were given a single dose of
162 μg of TiO2, CeO2, or CB NPs suspension in a vol-
ume of 50 μl by intratracheal instillation, intravenous in-
jection and oral gavage. Control mice received 50 μl of
2% serum (in nanopure water) that served as a vehicle
for the preparation of NPs suspension. The dose used in
the experiment was equal to the pulmonary deposition
after nine 8 h working days at the Danish occupational
exposure limit of 3.5 mg/m3 for CB [14]. Occupational
exposure concentrations of up to 15 mg/m3 CB have
been reported and the current dose would correspond to
the pulmonary deposition during 2.2 work-days [28].
Mice subjected to intratracheal instillation and intraven-
ous injection were anaesthetized with 0.5 ml/100 g body
weight of Hypnorm® (Fentanyl citrate 0.315 mg/ml and
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Fluanisone 10 mg/ml, Nomeco) and Dormicum® (Mid-
azolam 5 mg/ml, Roche) by subcutaneous injection in
the neck prior the NP administration. Orally gavaged
mice were not anaesthetized before the administration.
Pulmonary exposed mice were dosed by intratracheal in-
stillation as described previously [29]. In short, the se-
dated mice devoted for intratracheal instillation were
placed on a 40° slope (upside down, with the head to-
wards the floor) and a diode lamp was placed on the lar-
ynx to assure better visualization of the airways. The
tongue was pressed down towards the lower jaw using a
small spatula. 22 GA BD Insyte catheter (Becton Dickin-
son, Utah, USA) with a shortened needle used to intubate
the trachea. The proper position of each catheter was con-
firmed by a highly sensitive pressure transducer. In a
250 μl SGE glass syringe (250F–LT-GT, MicroLab, Aarhus,
Denmark) a volume of 50 μl of NP suspension followed by
200 μl air was instilled. Control groups received 50 μl of a
control vehicle prepared as described above. After the re-
moval of the catheter mice were placed back into vertical
position with the head up to assure that the NP suspension
remains in the lung and that the airways are unobstructed.
We have previously shown the overall and even pulmonary
distribution of particles using this exposure technique [30,
31]. Mice devoted for intravenous injection were restrained
in plexiglas restraining tubes with the tail hanging out of
the tube. Injection was performed using 0.4 x 20 mm nee-
dle (Terumo Europe, n.v. 3001, Leuven, Belgium). After
the exposure, sedated mice were placed back to their cages,
heated with a heating lamp and/or warming blanket and
monitored until they fully recovered from anesthesia. Mice
devoted for oral gavage were immobilized in a vertical pos-
ition and the gavage needle was inserted into the esopha-
gus and further toward the stomach to release the
suspension of particles. After the exposure, mice returned
to the cages and were closely monitored.
Necropsy and cells & tissues collection
One, 28 and 180 days following administration of NPs
mice were sedated by Hypnorm/Dormicum mixture (0.5–
0.7 ml/100 g body weight) followed by the exsanguination
by withdrawing the heart blood. Abdomen and thorax of
mice were opened and macroscopic examination of all or-
gans was performed. All observed abnormalities were
noted. After withdrawal of the heart blood in the intratra-
cheally instilled mice bronchoalveolar lavage (BAL) was
performed (N = 6 mice/group). Lungs were flushed twice
through the trachea with 0.8 ml of 0.9% sterile saline
(NaCl) as described [32]. Each flush consisted of 3 up and
down movements and was performed slowly (5–10 s
each). The BAL was stored on ice until the centrifugation
at 400 g for 10 min at 4 °C (Ole Dich centrifuge) was per-
formed. The supernatant, BAL fluid (BALF), was collected
in 1.5 ml tubes, snap-frozen in liquid nitrogen and stored
at −80 °C until used. The BAL cells were re-suspended in
100 μl HAMS-F12 medium (HAMS-F12, GIBCO #21765,
with 1% penicillin/streptomycin and 10% fetal bovine
serum). BAL cells devoted for comet assay were prepared
by the following procedure as described [32]: 40 μl of the
cell suspension was mixed with 60 μl of cell culture freez-
ing medium (HAMS-F12 with 1% penicillin/streptomycin,
10% fetal bovine serum and 10% of DMSO), divided into
two 50 μl aliquots and stored at −80 °C until used. The
total number of cells presented in the BAL fluid was de-
termined using the Nucleo-Counter NC-100 with Nucleo-
Cassette™ (Chemometec, Allerød, Denmark). 20 μl of the
cell suspension was mixed with 180 μl HAMS F12
medium, suspension was divided into 2 aliquots and live/
dead cells were counted according to the manufacturer’s
instructions. For the estimation of cellular composition in
BAL fluid rest of the cell suspension (approximately 40 μl)
was deposited on the microscope slide by centrifugation
at room temperature for 10 min. at 550 g in a Cytofuge® 2
(StatSpin, TRIOLAB, Brønby, Denmark). The slides were
fixed in 96% ethanol for 5 min and stained with May-
Grünwald-Giemsa dye using standard staining protocol.
The cellular composition was quantified on 200 cells
under light microscope (100 x magnifications). The liver
(N = 9/group) and lungs (from BAL flushed mice, N = 6/
group) were divided into specific pieces, snap frozen in li-
quid nitrogen in cryotubes (NUNC) and stored at −80 °C
for later use. For all mice throughout the whole experi-
ment samples were taken from the same parts of organs.
Specimens from livers (N = 9/group) and lungs (from mice
that had not been used for BALF collection, N = 3/group)
were fixed in 4% neutral buffered formaldehyde, paraffin-
embedded and 4 μm thick sections were stained with
hematoxylin and eosin for microscopical examination.
Table 1 Selected physicochemical parameters of the tested nanomaterials
TiO2 CeO2 CB
Source NanoAmorb Degussa/Quimidrogaa Evonik-Degussa
Product form Powder Powder Powder
Primary particle size 10.5 nmb 13.0 ± 12.1 nma 14 nmc
Specific surface area 139.1 m2/gb 56.7 m2/ga 295 m2/gd
Particle density 4.23 g/cm3 e 7.29 g/cm3 a 2.1 g/cm3 d
a[62]; b [63];c [29]; d [64]; e [65]
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Brightfield and darkfield microscopy
Cytoviva enhanced darkfield hyperspectral system (Auburn,
AL, USA) was used to detect particles in the liver tissue, by
scanning histological sections at 40 x in enhanced darkfield
mode. Darkfield images were acquired at 40 x and bright-
field images were acquired at 40× and 100 x on an Olym-
pus BX 43 microscope with a Qimaging Retiga4000R
camera. Uneven illumination in brightfield images was cor-
rected using ImageJ [33] and the Calculator Plus plugin via
the formula: Corrected_image = (image / background) *
255. The background image was a maximum projection of
3 background brightfield images without tissue.
Preparation of mRNA and cDNA from the liver and lung
tissue
Total RNA was isolated from the frozen liver and
lung tissue (16–20 mg) on Maxwell ® 16 (Promega,
USA) using Maxwell® 16 LEV simply RNA Tissue Kit
(AS1280, Promega, USA) following the manufacturer’s
protocol. Tissue lysis was performed by vigorously
shaking the samples using a Tissuelyser (Qiagen,
Denmark) with a 5 mm stainless steel beads for 60 s.
DEPC-treated nuclease-free water was used to elute
the mRNA. Complementary DNA (cDNA) was pre-
pared using TaqMan® reverse transcription reagents
(Applied Biosystem, USA) as stated in manufacturer’s
protocol. Concentration of total mRNA was deter-
mined by NanoDrop 2000c (ThermoFisher, USA).
Real-time RT-PCR
Gene expression levels of Saa1 in the liver tissue and
Saa3 in the lung tissue were assessed using quantitative
PCR as described previously [25, 34]. 18S RNA served as
a reference gene. Each of the analyzed samples was run
in triplicates using ViiA7 Real-Time PCR detector (Ap-
plied Biosystem, USA). TaqMan® predeveloped reagents
were used throughout the analysis. Target and reference
gene expression was quantified in triplicates in separate
wells. Target gene expression was determined by the
comparative method 2- ΔCt.
Comet assay
DNA strand break levels were quantified by the comet
assay in the liver and lung tissue and BAL cells as de-
scribed in [35]. In brief, single-cell suspension of the liver
and lung tissue was obtained by the homogenization of
the deep frozen liver and lung piece in an ice-cold Mer-
chant’s buffer through a stainless steel mesh (diameter
0.5 cm, mesh size 0.4 mm) mounted on a syringe, to yield
individual cells. The BAL fluid cells were thawed in a 37 °
C water bath before diluting with the Mechant’s buffer
without the filtration step. The cell suspension was em-
bedded in a low melting point agarose (0.7%) and depos-
ited on microscope Travigen 20-Well CometSlides™. The
slides were immersed in a lysing solution and stored over-
night at 4 °C. Subsequently, samples were treated with an
alkaline buffer and alkaline electrophoresis with circulat-
ing ice-cold electrophoresis buffer was performed
(25 min, 38 V/cm, 0.700 A). Thereafter, slides were neu-
tralized in neutralization buffer (0.4 M Tris, pH 7.5), fixed
with 96% ethanol and stained with a fluorescent DNA
intercalating dye SYBRGreen®. DNA strand breaks deter-
mined as the % of DNA in the comet tail (%TDNA) and
as the comet tail length (TL) were scored by the fully au-
tomated PatchFinder™ system (IMSTAR, France). In order
to control the day-to-day variation and to ensure equal
electrophoresis efficiency both negative (A549 human
lung epithelial cell line treated with PBS for 30 min at 4 °
C) and positive (A549 human lung epithelial cell line
treated with 60 μM H2O2 for 30 min at 4 °C,) controls
were included. The high throughput comet assay analysis
allowed analysis of all related sample on the same day de-
creasing potential variation due to the different electro-
phoresis or the duration of the incubation procedure.
Determination of ROS-generating ability of NPs
Assessment of NPs ability to generate ROS was per-
formed in vitro in a cell-free environment as described
previously [21, 36]. Briefly, 500 μl of 1 mM 2′,7′-
dichlorodihydrofluorescein diacetate (DCFH2-DA) (Invi-
trogen) was chemically hydrolyzed with 2 ml of 0.01 M
NaOH for 30 min to 2′,7′-dichlorodihydrofluorescein
(DCFH2). DCFH2-DA probe is light sensitive therefore
the experiment was conducted in a dark environment.
The formed DCFH2 was further diluted with 10 ml of
25 mM phosphate buffer (pH 7.4) to 0.04 mM. The NPs’
ability to generate ROS production was determined in
Hank’s balanced saline solution (HBSS, without phenol)
using a final DCFH2 concentration of 0.01 mM. Prior to
the assay, NPs were sonicated (Branson S-450D) for
16 min without a pause and further diluted in HBSS.
Generated ROS caused formation of 2′,7′-dichloro-
fluorescein (DCF) from DCFH2 that was spectrofluor-
imetrically measured following 3 h of incubation in
the dark (37 °C and 5% CO2). Excitation and emission
wavelengths were λex = 490 nm and λem = 520 nm,
respectively (Victor Wallac-2 1420; PerkinElmer,
Skovlunde, Denmark).
Statistical analysis
All presented values are expressed as mean ± standard
deviation (SD) unless differently stated. One-way or two-
way analysis of variance (ANOVA) was used to analyze
the data sets. In order to fulfil the normality and vari-
ance homogeneity criteria some variables were logarith-
mically transformed. Non-normally distributed data
were ranked before applying nonparametric one-way or
two-way ANOVA analysis. If the statistical significance
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was reached in the ANOVA analysis, Tukey post-hoc
multiple comparison test was used to test the differences
between the test groups. P-value ≤0.05 was considered
significant. All statistical analyses were calculated using
SAS 9.4 statistical software (SAS Institute Inc., Cary,
NC, USA).
Results
DLS
Dynamic light scattering (DLS) was used to determine
particle agglomerate size of TiO2, CeO2 and CB NPs
suspensions. The both the hydrodynamic number-based
size distribution revealed a narrow, unimodal peak with
the average diameter below 100 nm for all particle sus-
pensions (Fig. 1). The intensity size distributions also
showed unimodal peaks (Fig. 1). The median particle
diameter measured for TiO2, CeO2 and CB NPs was
68 nm, 68 nm, and 51 nm, respectively. Z-average and
polydispersity index were 131.4 and 0.120, respectively,
for TiO2, 148.8 and 0.174, respectively, for CeO2, 104.3
and 0.157, respectively, for CB NPs.
BAL fluid cellular composition
Analysis of BAL fluid cellular composition following pul-
monary exposure to the NPs revealed that intratracheal
instillation of all three particles resulted in increased
numbers of total cell counts after day 1 as well as in-
creased neutrophil influx in lungs 1 and 28 days post-
exposure (Fig. 2 and Table 2). Elevation in number of
total cell counts after day 1 as well as increased number
of neutrophils at day 1 and day 28 is consistent with pre-
vious studies [29, 37, 38]. The distributions of total cells,
neutrophils, macrophages, lymphocytes, eosinophils are
shown in Table 2.
Saa3 mRNA expression in the lung tissue
Pulmonary acute phase response was assessed as Saa3
mRNA expression levels [39, 40]. Analysis of Saa3 gene
expression revealed acute phase response in the lungs
following intratracheal instillation of TiO2, CeO2 and CB
NPs at all three time points. After day 1 and day 28, pul-
monary Saa3 mRNA levels were statistically significantly
increased compared to the vehicle control for all three
particles (P ≤ 0.001) with no differences between parti-
cles. After day 180, pulmonary Saa3 mRNA levels were
statistically significantly increased for TiO2 (P ≤ 0.01)
and CB (P ≤ 0.001) groups with no observed differences
between particles (Fig. 3 and Additional file 1).
Overall, our results indicate that pulmonary exposure
to all three NPs induces pulmonary inflammation and
pulmonary acute phase response.
Hepatic presence of NPs
Hepatic detection of NPs 180 days after intravenous in-
jection and intratracheal instillation by enhanced dark-
field microscopy and brightfield microscopy is presented
in Fig. 4. Aggregates of foreign material, visible as white
spots were present in liver tissue from mice exposed to
TiO2 and CeO2 NPs (Fig. 4B and C, selected NPs
marked with white arrowheads). In the livers from mice
exposed to CB NPs, black aggregates of foreign material
were present (Fig. 4D, selected NPs marked with black
arrowheads). Following IT exposure (Fig. 4B-D, panel 2)
foreign material aggregates were smaller and much less
frequent than aggregates detected in the liver tissue after
IV exposure (Fig. B-D, panel 1). In all exposure groups
aggregates were primarily detected in sinusoids and
partly perivascular and often appeared to be phagocy-
tized by Kupffer cells. Black or white spots were occa-
sionally also seen in vehicle controls, but the appearance
and location indicated artefacts from tissue preparation.
Fig. 1 Dynamic light scattering intensity size and number-based size
distributions of TiO2, CeO2 and CB NPs in suspension (3.24 mg/ml in
2% serum in nanopure water)
Fig. 2 Number of neutrophils detected in BAL fluid following
intratracheal instillation of 162 μg of TiO2, CeO2 or CB NPs
measured 1, 28 and 180 days after exposure. Particle exposed
groups n = 6, vehicle control n = 6. All values are presented as
mean + SD. An asterisk (*) denotes P ≤ 0.05, (**) P ≤ 0.01, (***)
P ≤ 0.001 of neutrophil levels in exposed groups versus vehicle control
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No exposure related foreign material aggregates were
identified following oral exposure (results not shown.)
Saa1 mRNA expression in liver tissue
Hepatic acute phase response was assessed by the meas-
urement of Saa1 mRNA expression levels [39]. Analysis
of Saa1 gene expression revealed hepatic acute phase re-
sponse on day 1 following intratracheal instillation and
intravenous injection (Fig. 5 and Additional file 2). No
NP-related effects on hepatic Saa1 expression levels
were observed at later time points.
One day following intratracheal instillation, hepatic
Saa1 mRNA levels were statistically significantly increased
for TiO2 (P ≤ 0.01) and CeO2 (P ≤ 0.001) exposed groups
as compared to the vehicle control. CeO2 NPs exposure
induced statistically significant higher hepatic Saa1
mRNA levels than TiO2 (P ≤ 0.05) and CB (P ≤ 0.001).
One day following intravenous injection, hepatic Saa1
mRNA level was statistically significantly increased for
TiO2 exposed mice compared to the vehicle control
(P ≤ 0.01). TiO2 exposure induced statistically signifi-
cantly higher hepatic Saa1 mRNA levels compared to
CeO2 (P ≤ 0.001) and CB (P ≤ 0.05) exposure.
DNA strand breaks in liver and lung
DNA strand break levels were determined in the liver
and lung tissue as well as in the BAL cells using comet
assay (Tables 3 and 4 and Figs. 6 and 7).
In the pulmonary exposed groups DNA strand break
levels in the liver tissue expressed as % tail DNA (%TDNA)
were statistically significantly increased compared to the
Table 2 BAL fluid cellular composition following intratracheal instillation of 162 μg of TiO2, CeO2 or CB NPs 1, 28 and 180 days
post-exposure
BAL fluid cellular composition after day 1
Control TiO2 CeO2 CB
Total cells (× 105) 0.9 ± 0.6 2.5 ± 0.9** 3.4 ± 1.1*** 2.4 ± 1.0**
Neutrophils (× 104) 0.2 ± 0.2 20.2 ± 8.5*** 26.1 ± 9.5*** 20.1 ± 8.3***
Macrophages (× 104) 9.0 ± 5.7 4.5 ± 1.9 6.1 ± 1.5 2.9 ± 1.5**
Lymphocytes (× 102) 1.9 ± 2.9 0.0 ± 0.0 7.1 ± 7.9 0.0 ± 0.0
Eosinophils (×103) 0.0 ± 0.1 3.0 ± 2.5** 13.3 ± 9.2*** 7.6 ± 6.8**
BAL fluid cellular composition after day 28
Control TiO2 CeO2 CB
Total cells (× 105) 1.4 ± 0.5 1.1 ± 0.2 1.6 ± 0.7 1.6 ± 0.8
Neutrophils (×104) 0.6 ± 0.3 1.9 ± 0.9* 2.6 ± 1.6** 3.8 ± 1.7***
Macrophages (×104) 7.9 ± 2.0 9.3 ± 2.3 12.9 ± 5.5 11.9 ± 5.5
Lymphocytes (×102) 8.5 ± 13.7 35.5 ± 44.3 28.3 ± 55.4 53.7 ± 78.1
Eosinophils (×103) 51.2 ± 39.3 0.1 ± 0.2** 0.2 ± 0.3* 0.0 ± 0.0***
BAL fluid cellular composition after day 180
Control TiO2 CeO2 CB
Total cells (× 105) 0.7 ± 0.3 1.0 ± 0.2 0.9 ± 0.3 1.3 ± 0.6
Neutrophils (×104) 0.3 ± 0.4 0.6 ± 0.4 0.3 ± 0.3 1.1 ± 0.7
Macrophages (×104) 7.0 ± 2.9 9.4 ± 2.1 8.4 ± 2.9 11.9 ± 4.9
Lymphocytes (×102) 0.0 ± 0.0 0.0 ± 0.0 0.5 ± 1.1 0.0 ± 0.0
Eosinophils (×103) 0.3 ± 0.4 0.4 ± 0.5 4.9 ± 6.8 4.9 ± 4.4
Particle exposed groups n = 6, vehicle control n = 6. All values are presented as mean ± SD. An asterisk (*) denotes P ≤ 0.05, (**) P ≤ 0.01, (***) P ≤ 0.001 of statistically
significantly different cells level in exposed groups versus vehicle control
Fig. 3 Pulmonary Saa3 mRNA expression levels in mice following
intratracheal instillation of 162 μg of TiO2, CeO2 or CB NPs measured
1, 28 and 180 days after the exposure. Saa3 mRNA levels were
normalized to 18S rRNA. Particle exposed groups n = 6, vehicle
control n = 6. All values are presented as mean + SD. Asterisks (**)
denote P ≤ 0.01, (***) P≤ 0.001 of Saa3 mRNA level in exposed
groups versus vehicle control
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vehicle control in the CB group (3.2 fold increase,
P ≤ 0.01) 28 days following exposure (Fig. 6). CB ex-
posure also induced statistically significantly higher
DNA strand break levels than TiO2 exposure (3.2
fold, P ≤ 0.01). 180 days after intratracheal instillation
%TDNA was statistically significantly increased for
CB exposed group compared to vehicle control (3.8
fold, P ≤ 0.001), TiO2 (3.9 fold, P ≤ 0.001) and CeO2
(2.4 fold, P ≤ 0.05) (Fig. 6 and Table 3).
Analysis of the %TDNA in liver tissue in intravenously
exposed groups revealed statistically significantly differ-
ences between CB and vehicle control and between CB
and TiO2 and CeO2 exposed groups (5.8, 5.9 and 4.8
fold increase, respectively, P ≤ 0.0001 for all groups)
Fig. 4 Enhanced darkfield (a-c) and brightfield (d) pictures of H&E
stained liver tissue from intravenously (IV) and intratracheally (IT)
exposed mice that received control vehicle (a) or 162 μg/animal of
TiO2 (b), CeO2 (c) or CB (d) NPs 180 days post-exposure. In the liver
sections of mice exposed to TiO2 and CeO2 light scattering aggregates
were observed using enhanced darkfield microscopy (b and c, selected
NPs marked with white arrowheads). In the liver sections of mice
exposed to CB NPs black aggregates were observed using brightfield
microscopy (d, selected NPs marked with black arrowheads)
Fig. 5 Hepatic Saa1 mRNA expression levels in mice following
intratracheal instillation (I.T.), intravenous injection (I.V.) and oral
gavage (P.O.) of 162 μg of TiO2, CeO2 or CB measured 1 day after
exposure. Particle exposed groups n = 9, vehicle control n = 9. All
values are presented as mean + SD. Asterisks (**) denote P ≤ 0.01
and (***) P ≤ 0.001 of Saa1 mRNA levels in exposed groups versus
vehicle control. Hashtag (#) denotes P ≤ 0.05 of Saa1 mRNA level in
TiO2 vs CB groups. Crosses (†††) denote P≤ 0.001 of Saa1 mRNA
level in CeO2 vs CB groups. Double cross (‡) denotes P ≤ 0.05 and
(‡‡‡) denote P ≤ 0.001 of Saa1 mRNA level in TiO2 vs CeO2 groups
Table 3 DNA strand break levels (% tail DNA) in liver tissue
following intratracheal instillation, intravenous injection and oral
gavage of 162 μg of TiO2, CeO2 or CB NPs 1, 28 and 180 days
after the exposure determined by the Comet assay
DNA SB in the liver following intratracheal instillation
Control TiO2 CeO2 CB
day 1 4.1 ± 4.6 4.3 ± 1.5 3.7 ± 1.4 5.6 ± 3.7
day 28 3.0 ± 1.4 2.9 ± 0.8 5.2 ± 5.9 9.4 ± 7.2**##
day 180 3.5 ± 0.8 3.4 ± 1.0 5.5 ± 2.4 12.2 ± 8.7***###†
DNA SB in the liver following intravenous injection
Control TiO2 CeO2 CB
day 1 3.1 ± 0.9 3.0 ± 1.0 3.7 ± 1.1 17.9 ± 7.9***###†††
day 28 5.2 ± 4.0 3.6 ± 1.1 9.7 ± 4.9 16.1 ± 10.2***###
day 180 3.3 ± 0.7 5.8 ± 7.2 3.7 ± 2.0 22.8 ± 11.1***###†††
DNA SB in the liver following oral gavage
Control TiO2 CeO2 CB
day 1 5.5 ± 3.8 4.6 ± 3.5 7.9 ± 8.6 13.9 ± 10.4
day 28 3.0 ± 0.6 2.8 ± 0.6 3.3 ± 0.7 2.4 ± 0.6
day 180 2.8 ± 0.8 3.5 ± 0.9 3.8 ± 3.5 7.2 ± 6.5
Particle exposed groups n = 9, vehicle control n = 9. All values are presented as
mean ± SD. Asterisks (**) denote P ≤ 0.01, (***) P ≤ 0.001 of DNA SB levels in
exposed groups versus vehicle control. Hashtags (##) denote P ≤ 0.01 and (###)
P ≤ 0.001 of DNA SB levels in the CB groups compared to TiO2 groups. Cross
(†) denotes P ≤ 0.05, (†††) P ≤ 0.001 of DNA SB levels in the CB groups
compared to CeO2 groups
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1 day following intravenous injection (Fig. 7). 28 days
post-exposure, DNA strand break levels in liver tissue in
the CB group were statistically significantly increased
compared to vehicle control (3.1 fold, P ≤ 0.001) and
TiO2 exposed group (4.4 fold, P ≤ 0.0001). 180 days
following exposure, DNA strand break levels in liver
tissue in the CB group were statistically significantly
increased compared to vehicle control and TiO2 and
CeO2 exposed groups (6.9, 4.0 and 6.2 fold, respectively,
P ≤ 0.0001 for all groups) (Table 3 and Fig. 7).
In the orally exposed groups %TDNA levels the liver
tissue were unaffected by exposure at all assessed time
points (Table 3).
In the lung tissue after intratracheal instillation
%TDNA was unaffected by the exposure after day 1 and
day 28 whereas significant increase in %TDNA was mea-
sured in TiO2 group compared to vehicle control (1.5
fold increase, P ≤ 0.05) 180 days post instillation
(Table 4). In the BAL cells %TDNA was unaffected by
the exposure after day 1 and day 28 (Table 4). DNA
strand breaks in the BAL cells 180 days following expos-
ure were not analyzed as the samples were lost.
ROS-generation assay
Among analyzed NPs, CB exhibited the greatest ability
to generate ROS (Fig. 8). CeO2 NPs also generated ROS
but the level was negligible and only marginally elevated
Table 4 DNA strand break levels (% tail DNA) in lung tissue 1,
28 and 180 days following intratracheal instillation and from the
BAL cells 1 and 28 days following intratracheal instillation of
162 μg of TiO2, CeO2 or CB determined by the Comet assay
DNA SB in the lungs following intratracheal instillation
Control TiO2 CeO2 CB
day 1 3.3 ± 0.8 3.2 ± 0.9 3.8 ± 0.6 4.6 ± 1.0
day 28 6.1 ± 1.3 5.9 ± 0.9 5.5 ± 1.1 5.3 ± 1.2
day 180 3.6 ± 1.0 5.2 ± 0.9* 4.2 ± 1.1 5.1 ± 1.4
DNA SB in the BAL cells following intratracheal instillation
Control TiO2 CeO2 CB
day 1 4.5 ± 0.7 4.4 ± 0.9 5.6 ± 1.3 5.8 ± 1.2
day 28 5.9 ± 1.1 4.0 ± 1.0 4.3 ± 1.0 4.0 ± 1.4
Particle exposed groups n = 6, vehicle control n = 6. All values are presented as
mean ± SD. An asterisk (*) denotes P ≤ 0.05 of DNA SB levels in exposed groups
versus vehicle control
Fig. 6 DNA strand break levels in the liver tissue (% tail DNA)
detected by comet assay following intratracheal instillation of
162 μg of TiO2, CeO2, CB measured 1, 28 and 180 days after
exposure. Particle exposed groups n = 9, vehicle control n = 9. All
values are presented as mean + SD. Asterisks (**) denote P ≤ 0.01,
(***) denote P ≤ 0.001 of DNA SB level in exposed groups versus
vehicle control. Hashtags (##) denote P ≤ 0.01, (###) denote P ≤
0.001 of DNA SB level in TiO2 vs CB groups. Cross (†) denotes P≤
0.05 of DNA SB level in CeO2 vs CB groups
Fig. 7 DNA strand break levels in the liver tissue (% tail DNA)
detected by comet assay following intravenous injection of 162 μg
of TiO2, CeO2 or CB NPs measured 1, 28 and 180 days after exposure.
Particle exposed groups n = 9, vehicle control n = 9. All values are
presented as mean + SD. Asterisks (***) denote P≤ 0.001 of DNA SB
level in exposed groups versus vehicle control. Hashtags (###) denote
P≤ 0.001 of DNA SB level in TiO2 vs CB groups. Crosses (†††) denote
P≤ 0.001 of DNA SB level in CeO2 vs CB groups
Fig. 8 NPs-induced generation of reactive oxygen species (ROS)
measured in a cell-free assay. All values are presented as mean +/−
SD from 3 independent measurements
Modrzynska et al. Particle and Fibre Toxicology  (2018) 15:2 Page 8 of 12
above background. There was no signal detected for
TiO2 at any of the analyzed concentrations.
Discussion
We have previously observed that pulmonary exposure
to reactive NPs induced genotoxicity in the liver tissue
[14, 17, 25, 41]. Therefore, in the present work, we
wanted to determine whether the observed hepatic DNA
strand breaks following pulmonary exposure to CB NPs
were caused by primary genotoxicity due to the direct
effects of translocated particles and their ability to in-
duce reactive oxygen species formation [21] or by sec-
ondary genotoxicity caused by pulmonary inflammation
and acute phase response triggering molecular signaling
cascade (release of cytokines, chemokines and ROS/
RNS) that, in turn, initiate downstream toxic effects in
the liver [41, 42].
Hepatic genotoxicity and possible mechanism for the
adverse hepatic effects
We found evidence of particle translocation from lung
to liver for all three NPs using darkfield and brigthfield
microscopy. In relation to the current study, we have
also quantified the extrapulmonary translocation of
CeO2 and TiO2 NPs following intratracheal exposure
using inductively coupled plasma mass spectrometry
(ICP-MS) and confirmed translocation of CeO2 and
TiO2 to the liver (Modrzynska et al., submitted for
publication).
In the present study, intravenous injection of CB NPs
resulted in increased DNA strand break (SB) levels in
liver 1, 28 and 180 days post-exposure, whereas intratra-
cheal instillation of CB induced DNA SBs in liver 28 and
180 days post-exposure. Significant translocation of
TiO2 NPs from lung to liver was recently demonstrated
using radioactively labelled TiO2 NPs [7]. In agreement
with this, we also detected intratracheally instilled TiO2
and CeO2 NPs in the liver 180 days post-exposure by
darkfield microscopy. The fact that hepatic genotoxicity
was only observed at the later time points following pul-
monary exposure might reflect the time needed for par-
ticles to translocate in sufficient amounts from lungs to
the liver [7].
It has been previously suggested by Jackson [41] that
the observed liver DNA SBs could be a result of gastro-
intestinal tract exposure due to the whole-body inhal-
ation and further fur grooming. Minute uptake of TiO2
NPs following oral exposure has been reported [7, 43,
44] and it was recently estimated that up to 20% of TiO2
NPs accumulated in liver following pulmonary exposure
had reached the liver by the oral route [7]. However, we
have found no detectable translocation of CeO2 and
TiO2 NPs in the liver after oral exposure. Overall, no
hepatotoxic effects were observed following oral gavage
since the dosing did not elicit neither acute phase re-
sponse nor genotoxicity in the liver. This indicates that
the secondary oral exposure caused by swallowing a por-
tion of lung-deposited particles did not contribute to the
observed adverse effects. In general, larger dose or re-
peated oral exposure were needed to evoke the toxic ef-
fect observed in the other studies [26, 45, 46].
CB is a well characterized carbonaceous nanomaterial
and very potent ROS generator [22, 47, 48]. Exposure to
CB NPs has been shown to induce oxidative DNA dam-
age, increased levels of DNA strand breaks [21, 49] as
well as mutagenicity in vivo and in vitro [22, 50]. The
mutation spectrum observed in vitro is consistent with
being caused by oxidative DNA damage [47]. The afore-
mentioned studies are in a good agreement with the
present results, showing that CB is much more potent in
terms of generating ROS than TiO2 and CeO2 NPs.
Moreover, CB NPs contain very low levels of organic im-
purities [22, 51, 52] that excludes the hypothesis that
CB-induced genotoxicity is caused by polycyclic
aromatic hydrocarbons (PAH) that are absorbed on par-
ticles’ surface.
Pulmonary acute phase response but no hepatic acute
phase response
In our previous studies [13, 15, 40, 53, 54] we demon-
strated that Saa3 was the most upregulated acute phase
gene during pulmonary acute phase response and, fre-
quently, the most differentially expressed gene. Saa1 was
the most differentially expressed acute phase response
gene in the liver [39]. Therefore, Saa3 mRNA expression
levels were used as a biomarker for pulmonary acute
phase response whereas Saa1 expression was used as a
biomarker for hepatic acute phase response [55].
Pulmonary exposure to all three NPs induced similar
pulmonary inflammation in terms of neutrophil influx
that persisted up to day 28 and long-lasting pulmonary
acute phase response that sustained for 180 days. The
highest induction of acute phase was observed after day
1 and declined in a time-dependent manner remaining
elevated for TiO2 and CB NPs 180 days following expos-
ure. Pulmonary acute phase response was similar for all
three particles when compared to the control and no dif-
ferences between particles were observed. Thus, if the
hepatic genotoxicity was caused by systemic circulation
of pulmonary inflammatory messengers, then all the
assessed NPs would induce hepatic genotoxicity. Instead,
hepatic genotoxicity was only observed in CB exposed
groups. Therefore, it is unlikely that circulating cytokines
released by pulmonary-mediated inflammation and acute
phase response caused the DNA lesions. Moreover, a re-
cent meta-analysis of global transcriptional pattern fol-
lowing pulmonary exposure to CB and TiO2 NPs
indicated that exposure to CB and TiO2 induced similar
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changes in pulmonary transcription [56]. Both materials
evoked comparable neutrophilic-dominated lung inflam-
mation and similarly altered expression level of many
pro-inflammatory genes. In addition, our previous stud-
ies indicated that CB [16] and TiO2 [53] NPs induced
similar alterations in the expression profile of selected
cytokines genes in the lung tissue. Demonstrated resem-
blances in the elicited pulmonary response following ex-
posure to CB and TiO2 should lead to the similar
induction level of different secondary mediators that
would cause similar level of hepatic DNA SBs in both
exposure groups. Instead, we have only observed hepatic
genotoxicity in the CB NPs exposed mice, which is an
additional evidence of primary genotoxicity caused by
the deposited CB NPs rather than by the effects of circu-
lating secondary mediators.
In the present study, we found induction of hepatic
acute phase response following lung instillation of TiO2
NPs and CeO2 NPs and following intravenous injection
of TiO2 NPs that was present at day 1 but has already
subsided by the day 28. Induction of hepatic acute phase
response was much weaker and shorter than the pul-
monary acute-phase response. Pulmonary exposure to
TiO2 increased pulmonary Saa3 expression level 100-
fold whereas 17.3 fold induction and 9.4 fold induction
of hepatic Saa1 was measured after intravenous injection
and intratracheal instillation, respectively. No acute phase
response was detected in the liver of orally gavaged ani-
mals. In addition CB NPs exposure by IV or IT, in contrast
to TiO2 and CeO2 did not induce hepatic acute phase re-
sponse, therefore hepatic acute phase response is also not
a likely cause of the observed genotoxicity.
We have previously reported transient or no hepatic
acute phase response following pulmonary exposure
measured by analysis of the transcriptional changes in
liver mRNA of mice exposed to diesel exhaust particles
(DEP), CB, multi walled carbon nanotubes [13, 39].
Transient acute phase response in the liver tissue was
also reported after pulmonary exposure to 162 μg/mouse
of TiO2 as reported by [25]. Hepatic acute phase re-
sponse induced by intravenous injection of gold particles
has been reported by Zhang and co-workers [57]. They
used Saa reporter mouse model to detect transcriptional
activation of hepatic Saa using bioluminescence im-
aging. Their results demonstrated that among all of the
assessed particles 50 nm Au nanospheres exhibited the
highest capacity to induce activation of hepatic Saa. The
highest activation was detected 4 h following intraven-
ous injection. The signal was transient and gradually de-
clined. In the present study lack of detection of hepatic
acute phase response after intravenous injection of CeO2
and CB at all three time points as well as temporary in-
duction of acute phase response in the TiO2 group on
day 1 could be explained by the brief and transient
nature of acute phase response induction in the liver
that causes difficulties in the measurement.
Overall, our results suggest that the observed hepatic
DNA damage following IV and IT exposure to CB was
caused by the presence of translocated NPs in the liver
and their ability to induce oxidative stress rather than by
secondary effects of pulmonary inflammation and acute
phase response. Particles deposited in the liver are pri-
mary accumulated in the Kupffer cells [58]. In the
current study, we observed foreign material in sinusoids
and in Kupffer cells. Only a small fraction of the liver
cells appeared to be directly exposed to the particle-
generated ROS [41]. Apparently, this was sufficient to
induce hepatic genotoxicity.
Our results may also imply that inhaled carbon nano-
particles could induce hepatic genotoxicity leading to
liver carcinogenesis. It is supported by epidemiological
studies showing that exposure to traffic related air pollu-
tion is associated with risk of liver cancer [59, 60]. The
International Agency for Research on Cancer (IARC)
has classified CB NPs as possibly carcinogenic to
humans [61]. It can be speculated that the presence of
CB NPs in the liver may, in a long-time perspective,
contribute to the onset of cancer.
Conclusions
Pulmonary exposure to three different NPs, TiO2, CeO2
and CB induced long lasting pulmonary inflammation
and acute phase response. Indications of translocation to
the liver were found for all three NPs. However, only CB
dosed by IT and IV induced hepatic genotoxicity. There-
fore, our findings indicate that hepatic DNA strand
breaks following pulmonary exposure to CB are likely
caused by direct effects of CB NPs that translocate from
lung to liver rather than being caused by inflammatory
or acute phase responses. Furthermore, the lack of par-
ticle translocation, inflammation and acute phase re-
sponse following oral exposure to NPs suggest that the
secondary oral exposure following pulmonary clearance
of inhaled particles does not contribute to the observed
hepatic genotoxicity.
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